$LASE
Laser Photonics Corp Stock $lase

$lase Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224034236 Filed on August 29, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$669.2K	$623.4K	$968.1K
YoY Change	-46.01%	-35.6%	-28.49%
Cost Of Revenue	$107.3K	$308.1K	$283.9K
YoY Change	-67.82%	8.53%	-30.87%
Gross Profit	$609.4K	$315.4K	$684.2K
YoY Change	-32.75%	-53.91%	-27.45%
Gross Profit Margin	91.07%	50.58%	70.68%
Selling, General & Admin	$1.608M	$1.881M	$868.1K
YoY Change	-13.11%	116.72%	62.96%
% of Gross Profit	263.82%	596.59%	126.88%
Research & Development	$62.80K	$60.23K	$40.21K
YoY Change	-16.74%	49.81%
% of Gross Profit	10.31%	19.1%	5.88%
Depreciation & Amortization	$238.6K	$245.9K	$100.9K
YoY Change	176.93%	143.6%	20.05%
% of Gross Profit	39.16%	77.97%	14.75%
Operating Expenses	$2.315M	$2.426M	$654.8K
YoY Change	15.61%	270.55%	7.38%
Operating Profit	-$1.706M	-$2.111M	$29.43K
YoY Change	55.59%	-7272.41%	-91.17%
Interest Expense			$0.00
YoY Change			-100.0%
% of Operating Profit			0.0%
Other Income/Expense, Net	$80.63K	-$2.723K	-$639.00
YoY Change		326.13%	-93.62%
Pretax Income	-$1.625M	-$2.114M	$28.79K
YoY Change	48.24%	-7441.05%	-91.09%
Income Tax			$0.00
% Of Pretax Income			0.0%
Net Earnings	-$1.625M	-$2.114M	$28.79K
YoY Change	48.24%	-7441.05%	-91.09%
Net Earnings / Revenue	-242.87%	-339.02%	2.97%
Basic Earnings Per Share	-$0.13	-$0.20	$0.00
Diluted Earnings Per Share	-$0.13	-$0.20	$0.00
COMMON SHARES
Basic Shares Outstanding	12.27M shares	9.270M shares	7.878M shares
Diluted Shares Outstanding	12.67M shares	10.59M shares	7.878M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.122M	$2.748M	$9.885M
YoY Change	-74.47%	-72.2%	1730.13%
Cash & Equivalents	$2.122M	$2.748M	$9.885M
Short-Term Investments
Other Short-Term Assets	$40.79K	$405.6K	$3.953M
YoY Change	-39.07%	-89.74%
Inventory	$1.831M	$2.105M	$2.216M
Prepaid Expenses
Receivables	$773.3K	$446.0K	$1.405M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.767M	$5.705M	$13.84M
YoY Change	-62.3%	-58.77%	386.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.258M	$923.7K	$742.1K
YoY Change	65.46%	24.47%	15.22%
Goodwill
YoY Change
Intangibles	$4.027M	$4.078M
YoY Change
Long-Term Investments	$316.4K
YoY Change
Other Assets			$332.0K
YoY Change			7428.73%
Total Long-Term Assets	$5.854M	$5.376M	$4.243M
YoY Change	41.25%	26.7%	2.11%
TOTAL ASSETS
Total Short-Term Assets	$4.767M	$5.705M	$13.84M
Total Long-Term Assets	$5.854M	$5.376M	$4.243M
Total Assets	$10.62M	$11.08M	$18.08M
YoY Change	-36.74%	-38.72%	158.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$533.9K	$198.2K	$295.9K
YoY Change	128.84%	-32.99%	50.03%
Accrued Expenses	$30.08K	$107.6K	$344.5K
YoY Change	-91.46%	-68.76%	137.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$886.8K	$620.0K	$640.4K
YoY Change	51.42%	-3.18%	54.87%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$46.35K	$177.0K	$305.9K
YoY Change	-80.37%	-42.15%	-6.74%
Total Long-Term Liabilities	$46.35K	$176.9K	$305.9K
YoY Change	-80.37%	-42.15%	-6.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$886.8K	$620.0K	$640.4K
Total Long-Term Liabilities	$46.35K	$176.9K	$305.9K
Total Liabilities	$933.1K	$797.0K	$946.3K
YoY Change	13.55%	-15.78%	27.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.341M	-$8.914M	-$728.2K
YoY Change	158.42%	1124.22%	-175.13%
Common Stock	$13.83K	$12.27K	$82.53K
YoY Change	-83.24%	-85.13%	69.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$25.24K	$25.24K
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.688M	$10.28M	$17.13M
YoY Change
Total Liabilities & Shareholders Equity	$10.62M	$11.08M	$18.08M
YoY Change	-36.74%	-38.72%	158.21%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.625M	-$2.114M	$28.79K
YoY Change	48.24%	-7441.05%	-91.09%
Depreciation, Depletion And Amortization	$238.6K	$245.9K	$100.9K
YoY Change	176.93%	143.6%	20.05%
Cash From Operating Activities	-$3.189M	-$2.388M	-$1.838M
YoY Change	706.0%	29.89%	-756.26%
INVESTING ACTIVITIES
Capital Expenditures	$88.88K	$38.00K	$139.3K
YoY Change	-34.44%	-72.73%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$88.88K	-$38.00K	-$139.3K
YoY Change	-34.44%	-72.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.652M		1.046M
YoY Change	-352.6%		-606.68%
NET CHANGE
Cash From Operating Activities	-3.189M	-2.388M	-1.838M
Cash From Investing Activities	-88.88K	-38.00K	-139.3K
Cash From Financing Activities	2.652M		1.046M
Net Change In Cash	-625.9K	-2.426M	-931.2K
YoY Change	-60.42%	160.48%	-1365.32%
FREE CASH FLOW
Cash From Operating Activities	-$3.189M	-$2.388M	-$1.838M
Capital Expenditures	$88.88K	$38.00K	$139.3K
Free Cash Flow	-$3.278M	-$2.426M	-$1.977M
YoY Change	517.04%	22.66%	-806.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Not Applicable
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	LASE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12270427	shares
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	446016	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	405638	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	5704708	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	923674	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4077662	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	374559	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	198236	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	116564	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	197614	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	107614	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	620028	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	176945	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	176945	usd
CY2024Q2	us-gaap	Liabilities Liabilities	796973	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	12270	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	25240	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11080603	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	623435	usd
CY2024Q2	us-gaap	Assets Assets	11080603	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment		usd
	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment		usd
	us-gaap	Payments For Software PaymentsForSoftware		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	LASE	Share Issued For Purchase Of License ShareIssuedForPurchaseOfLicense		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6201137	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	816364	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2105421	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2237455	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	39190	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9294146	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	952811	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4279987	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2023Q4	us-gaap	Assets Assets	15124087	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	223040	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	213114	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434152	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	161538	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1031844	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162991	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	162991	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1194835	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Assets Assets	15124087	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	213114	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434152	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	161538	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1031844	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162991	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	162991	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1194835	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12270427	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9253419	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9228482	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	9253	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19211044	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19180725	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5235486	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	25240	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10283630	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13929252	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15124087	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	965440	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1366426	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1641632	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	308081	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	283864	usd
	us-gaap	Cost Of Revenue CostOfRevenue	665204	usd
	us-gaap	Cost Of Revenue CostOfRevenue	553761	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	315354	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	681576	usd
	us-gaap	Gross Profit GrossProfit	701222	usd
	us-gaap	Gross Profit GrossProfit	1087871	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	266282	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	522918	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	402891	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	785842	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1615082	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	393352	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	969217	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	245894	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100947	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12270427	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9253419	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12245490	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9228482	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	9253	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8914444	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5235486	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	25240	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13929252	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15124087	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	965440	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1366426	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1641632	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	308081	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	283864	usd
	us-gaap	Cost Of Revenue CostOfRevenue	665204	usd
	us-gaap	Cost Of Revenue CostOfRevenue	553761	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	315354	usd
	us-gaap	Gross Profit GrossProfit	701222	usd
	us-gaap	Gross Profit GrossProfit	1087871	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	266282	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	522918	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	402891	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	785842	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1615082	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	393352	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2991035	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	969217	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	245894	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100947	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	431210	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	184084	usd
CY2024Q2	us-gaap	Salaries And Wages SalariesAndWages	238703	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	302409	usd
	us-gaap	Salaries And Wages SalariesAndWages	646111	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60232	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40205	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107923	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	80459	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1359831	usd
	us-gaap	Operating Expenses OperatingExpenses	4380217	usd
	us-gaap	Operating Expenses OperatingExpenses	2665713	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2110839	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-678255	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	431210	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	184084	usd
CY2024Q2	us-gaap	Salaries And Wages SalariesAndWages	238703	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	302409	usd
	us-gaap	Salaries And Wages SalariesAndWages	447158	usd
	us-gaap	Salaries And Wages SalariesAndWages	646111	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60232	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40205	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107923	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	80459	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2426193	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1359831	usd
	us-gaap	Operating Expenses OperatingExpenses	4380217	usd
	us-gaap	Operating Expenses OperatingExpenses	2665713	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2110839	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3678995	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1577842	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2723	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-639	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	37	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-358657	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2113562	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-678894	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3678958	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1936499	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2113562	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-678894	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3678958	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1936499	usd
CY2024Q2	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment	6615000	usd
	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment	6615000.00	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8728562	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10293958	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1936499	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.82
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.82
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.04
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.25
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.25
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10589108	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10589108	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7878419	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7878419	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9924908	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3678995	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1577842	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2723	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-639	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	37	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-678894	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1936499	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2113562	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-678894	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3678958	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1936499	usd
CY2024Q2	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment	6615000	usd
	LASE	Deemed Dividend Adjustment DeemedDividendAdjustment	6615000.00	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8728562	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-678894	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10293958	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1936499	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.82
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.82
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.04
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.25
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.25
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10589108	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10589108	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9924908	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9924908	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7878419	shares
	us-gaap	Net Income Loss NetIncomeLoss	-1936499	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	33336	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	431210	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	184084	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-370348	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-664005	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-132034	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	493474	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	366448	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	209490	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-24804	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	26810	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-53924	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-322846	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-96550	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3253756	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2087409	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9924908	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7878419	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7878419	shares
	us-gaap	Net Income Loss NetIncomeLoss	-3678958	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1936499	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	33336	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	431210	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	184084	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-370348	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-664005	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-132034	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	493474	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	366448	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	209490	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-24804	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	26810	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-53924	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3253756	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2087409	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	12934	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	183941	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	4095	usd
	us-gaap	Payments For Software PaymentsForSoftware	6199	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	182719	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	19707	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-209847	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3453504	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2297256	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6201137	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12181799	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2747633	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9884543	usd
	LASE	Share Issued For Purchase Of License ShareIssuedForPurchaseOfLicense	6615000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13929252	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1565396	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	33336	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	12397192	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	12397192	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2113562	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	6615000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	6615000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10283630	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10283630	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131488	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131488	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1936499	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15194989	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15194989	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	12934	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	183941	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	4095	usd
	us-gaap	Payments For Software PaymentsForSoftware	6199	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	182719	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	19707	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199748	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-209847	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3453504	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2297256	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6201137	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12181799	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2747633	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9884543	usd
	LASE	Share Issued For Purchase Of License ShareIssuedForPurchaseOfLicense	6615000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13929252	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1565396	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	33336	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	12397192	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	12397192	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2113562	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	6615000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	6615000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10283630	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10283630	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131488	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131488	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1936499	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15194989	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15194989	usd
CY2024Q2	us-gaap	Deposits Deposits	2539472	usd
	LASE	Deposits Description DepositsDescription	The terms on this CD if flexible, having a term of 9 months that automatically renews, Full balance and interest can be withdrawn prior to maturity. A penalty of 7 days interest will be imposed for early withdrawals within the first 6 days of the account term.
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	223040	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	116564	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	213114	usd
CY2024Q2	us-gaap	Deposits Deposits	2539472	usd
	LASE	Deposits Description DepositsDescription	The terms on this CD if flexible, having a term of 9 months that automatically renews, Full balance and interest can be withdrawn prior to maturity. A penalty of 7 days interest will be imposed for early withdrawals within the first 6 days of the account term.
CY2024Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	198236	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	223040	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	116564	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	213114	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	446016	usd
CY2024Q2	LASE	Allowance Estimated Credit Losses AllowanceEstimatedCreditLosses	0	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	992741	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	862940	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	931227	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	992744	usd
CY2024Q2	LASE	Inventory Sales Demo InventorySalesDemo	258954	usd
CY2023Q4	LASE	Inventory Sales Demo InventorySalesDemo	162958	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	203683	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	243029	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	281184	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24216	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2105421	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2237455	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	446016	usd
CY2024Q2	LASE	Allowance Estimated Credit Losses AllowanceEstimatedCreditLosses	0	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	992741	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	862940	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	931227	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	992744	usd
CY2024Q2	LASE	Inventory Sales Demo InventorySalesDemo	258954	usd
CY2023Q4	LASE	Inventory Sales Demo InventorySalesDemo	162958	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	203683	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	243029	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	281184	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24216	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2105421	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2237455	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	958842	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	729956	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	923674	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	952811	usd
CY2024Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	927553	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	725228	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4077662	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4279987	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	958842	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	729956	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	923674	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	952811	usd
CY2024Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	927553	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	725228	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4077662	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4279987	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	79847	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	91062	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	159694	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	181670	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12270427	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2024Q2	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	626918	shares
CY2022Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	4688695	shares
CY2021Q4	us-gaap	Area Of Land AreaOfLand	18000
CY2021Q4	us-gaap	Variable Lease Payment VariableLeasePayment	15109	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	8000
CY2023Q4	us-gaap	Variable Lease Payment VariableLeasePayment	10000	usd
CY2021Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25109	usd
CY2022Q4	us-gaap	Area Of Land AreaOfLand	8000
CY2022Q4	us-gaap	Variable Lease Payment VariableLeasePayment	14805	usd
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434153	usd
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162990	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	374559	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	197614	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	176945	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	79847	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	159694	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	181670	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12270427	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2024Q2	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	626918	shares
CY2022Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	4688695	shares
CY2021Q4	us-gaap	Area Of Land AreaOfLand	18000
CY2021Q4	us-gaap	Variable Lease Payment VariableLeasePayment	15109	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	8000
CY2023Q4	us-gaap	Variable Lease Payment VariableLeasePayment	10000	usd
CY2021Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25109	usd
CY2022Q4	us-gaap	Area Of Land AreaOfLand	8000
CY2022Q4	us-gaap	Variable Lease Payment VariableLeasePayment	14805	usd
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434153	usd
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162990	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	374559	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	197614	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	197614	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	176945	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	374559	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	197614	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	176945	usd

Files In Submission

Name	View Source	Status
0001493152-24-034236-index-headers.html	Edgar Link	pending
0001493152-24-034236-index.html	Edgar Link	pending
0001493152-24-034236.txt	Edgar Link	pending
0001493152-24-034236-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
lase-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lase-20240630_cal.xml	Edgar Link	unprocessable
lase-20240630_def.xml	Edgar Link	unprocessable
lase-20240630_pre.xml	Edgar Link	unprocessable
lase-20240630_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LASE
Laser Photonics Corp Stock $lase

2024 Q3 Form 10-Q Financial Statement

#000149315224034236 Filed on August 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE Laser Photonics Corp Stock $lase

2024 Q3 Form 10-Q Financial Statement

#000149315224034236 Filed on August 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE
Laser Photonics Corp Stock $lase